Economic assessment on the management of chronic lymphocytic leukaemia

Author： Goor Kim M   Schaafsma M Ronald   Huijgens Peter C   van Agthoven Michel  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.7, 2005-06, pp. : 1179-1189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Chronic Lymphocytic Leukaemia

By Kalil N.   Cheson B.D.  

Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. : 9-27

Adis International

Access to resources Recommend Favorite

An update on the management of chronic lymphocytic leukaemia

By Yee Karen WL   O’Brien Susan M   Giles Francis J  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 7, 2004-07 ,pp. : 1535-1554

Informa Healthcare

Access to resources Recommend Favorite

Fludarabine in chronic lymphocytic leukaemia

By Elter Thomas   Hallek Michael   Engert Andreas  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1641-1651

Informa Healthcare

Access to resources Recommend Favorite

Chronic lymphocytic leukaemia

By Singer Charles   Goldstone Tony  

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 350-353

Royal College Of Physicians

Access to resources Recommend Favorite

Economic Evaluation of Third-Line Treatment with Alemtuzumab for Chronic Lymphocytic Leukaemia

By Scott W. Guy   Scott Helen M.  

Clinical Drug Investigation, Vol. 27, Iss. 11, 2007-01 ,pp. : 755-764

Adis International

Access to resources Recommend Favorite